Company Filing History:
1 out of 1,565 
1 out of 377 
Years Active: 2016
Title: Marc Freeman - Innovator in Neuroscience
Introduction
Marc Freeman is an innovative inventor based in Barre, Massachusetts. He holds one patent that focuses on therapeutic applications aimed at targeting SARM1, a key protein in the neural degradation process. His work seeks to provide methods for reducing axonal and synaptic degradation in neurons, addressing significant challenges in neuroscience.
Latest Patents
Marc Freeman's noteworthy patent involves the modulation of sterile α/Armadillo/Toll-Interleukin receptor homology domain protein (SARM) activity and/or expression. This method introduces new possibilities for therapeutic interventions aimed at preventing neuronal degeneration.
Career Highlights
Throughout his career, Marc Freeman has made significant contributions while working at renowned institutions such as the University of Massachusetts and the University of Miami. His expertise in neuroscience positions him as a valuable asset in the fields of research and innovation.
Collaborations
Marc Freeman has collaborated with Stephan Zuchner, a fellow researcher, to advance the understanding of neuronal processes and therapeutic strategies. Their joint efforts exemplify the power of collaboration in advancing scientific research.
Conclusion
Marc Freeman's contributions to neuroscience through his patent and collaborative efforts showcase his commitment to innovation. His work not only advances the field of neural research but also holds the potential for significant therapeutic applications.